Epidemiology of herpes simplex
The epidemiology of herpes simplex is of substantial
In many infections, the first symptom a person will have of their own infection is the horizontal transmission to a sexual partner or the
This information provides population prevalence of HSV viral infections in individuals with or without active disease. Note that there are population subgroups that are more vulnerable for HSV infections, such as
Seroprevalence estimates for HSV-1 and HSV-2[3] | ||||
Location | Year(s) | Prevalence (%) | ||
HSV-1 | HSV-2 | |||
Total | Female | Male | ||
Africa | ||||
Benin | 1997–8 | – | 30 | 12 |
Cameroon | 1997–8 | – | 46–51 | 24–27 |
Central African Republic | 1998–9 | 99 | 82 | – |
Eritrea | 1995 | 84–97 | 23 | 24–27 |
The Gambia | 1998–9 | – | 29–32 | 5 |
Kenya | 1997–8 | – | 68 | 35 |
Mali[5] | 1991–7 | 93 | 43 | – |
Morocco[5] | 1991–7 | 99 | 26 | – |
South Africa | 1999 | – | 53 | 17 |
Tanzania | 1992 | – | 42 | 19 |
Uganda | 1989–93 | 91 | 71 | 36 |
Zambia | 1997–8 | – | 55 | 36 |
Zimbabwe | 1993–8 | – | 67 | 36-53 |
Asia | ||||
Bangladesh | 1996–8 | 46# | 8–14 | – |
China | 1987–95 | – | 18–29 | 17 |
Israel | 1998–9 | 70 | 5 | 4 |
Japan | 1985–93 | 50–60 | 1–17 | 2 |
Jordan | <2000 | – | 41 | 53 |
South Korea[6] | 2004 | – | 28 | 22 |
Philippines | 1991–3 | – | 9 | – |
Syria | 1995–8 | 80–100 | 0 | 0–1 |
Thailand[3][5] | 1991–7 | 51 | 35 | 15 |
Turkey | 1991–2 | 97 | 42 | – |
Australasia | ||||
Australia | <1992–8 | 79–80 | 11–15 | - |
New Zealand | 1993–8 | – | 4–15 | 3–7 |
Central/South America | ||||
Brazil | 1990–7 | – | 23–42 | – |
Colombia[5] | 1985-97 | 89 | 57 | - |
Costa Rica | 1984–5 | – | 39 | – |
Haiti | <1992 | – | 54 | – |
Mexico | 1992–7 | – | 30 | – |
Peru[5] | 1991–7 | 92 | 36 | – |
Europe | ||||
Bulgaria[7] | 1999 | 84 | 15->40 | 15-30 |
Denmark | 1986 | 76 | 31 | – |
Finland | 1966–89 | – | 26–31 | – |
Germany | 1996–7 | 87 | 15 | 11 |
Greenland | 1986 | 98 | 68 | – |
Italy | 1981–8 | 81–93 | 1–5 | 0–5 |
Norway | 1992–4 | 79 | 27 | – |
Spain | 1992–3 | 79 | 4 | 4 |
Sweden | 1989–93 | 41# | 21–33 | – |
Switzerland | 1997 | 65–87 | 22 | 11 |
UK | 1984–95 | 69–78 | 5 | 3 |
North America | ||||
Canada | 1999 | 57 | 13 | – |
United States | 1988–94 | 68* | 26* | 18* |
# in children | ||||
* Ages 12-70 |
Europe
Large differences in HSV-1 seroprevalence are seen in different European countries. HSV-1 seroprevalence is high in Bulgaria (83.9%) and The Czech Republic (80.6%), and lower in Belgium (67.4%), The Netherlands (56.7%), and Finland (52.4%).[7]
The typical age at which HSV-1 infection is acquired ranges from 5 to 9 years in
HSV-2 seropositivity is widely distributed in Europeans older than 12, although there are large differences in the percentage of the population exposed to HSV-2. Bulgaria has a high (23.9%) HSV-2 seroprevalence relative to other European countries: Germany (13.9%), Finland (13.4%), Belgium (11.1%), The Netherlands (8.8%), the Czech Republic (6.0%), and England and Wales (4.2%).[7]
Women are more likely to be seropositive than men, and likely acquire the virus at an earlier age. In each country of Europe, HSV-2 seropositivity becomes more common from adolescence onwards and increases in the population with age, with a decline in the older age groups in some countries.[7]
North America
United States
The most recent data for HSV-2 was published in March 2010, based on a National Health and Nutrition Examination Survey study performed between 2005 and 2013 by CDC. About 1 in 6 Americans (16.2%) aged 14 to 49 is infected with HSV-2. HSV-2 prevalence was nearly twice as high among women (20.9%) than men (11.5%), and was more than three times higher among blacks (39.2%) than non-Hispanic whites (12.3%).[8]
The most affected group was black women, with a prevalence rate of 48%. Prevalence increased with age and number of partners. Only 18.9% of those infected had previously been aware of their infection.[8]
Demographic | HSV-2 Seroprevalence | (Females) | (Males) |
---|---|---|---|
Gender | 16.2% | 20.9% | 11.5% |
Age: 14–19 yrs | 1.4% | 2.1% | 0.8% |
Age: 20–29 yrs | 10.5% | 14.4% | 6.6% |
Age: 30–39 yrs | 19.6% | 25.2% | 13.9% |
Age: 40–49 yrs | 26.1% | 32.3% | 19.6% |
Ethnicity: White, non-Hispanic | 12.3% | 15.9% | 8.7% |
Ethnicity: Black, non-Hispanic | 39.2% | 48.0% | 29.0% |
Ethnicity: Mexican American | 10.1% | 13.2% | 7.5% |
1 lifetime sex partner | 3.9% | 5.4% | 1.7% |
2–4 lifetime sex partners | 14.0% | 18.8% | 7.3% |
5–9 lifetime sex partners | 16.3% | 21.8% | 10.1% |
>10 lifetime sex partners | 26.7% | 37.1% | 19.1% |
African Americans and immigrants from
In healthy adults, HSV-2 infection occurs more frequently in the United States than in Europe.
Seroprevalence rates in the United States appeared to be increasing, rising from 16.4% in 1976 to 21.8% in 1994.[12] However, this trend seems to have reversed itself in recent years, dropping to 17.2% in 2004.[13]
The current prevalence of genital herpes caused by HSV-2 in the U.S. is roughly one in four or five adults, with approximately 50 million people infected with genital herpes and an estimated 0.5 million new genital herpes infections occurring each year.
Due to the anatomical nature of the vagina women are at higher risk than men for acquiring HSV-2 infection, and the chance of being infected increases with age. This is evident despite women on average having a lower number of sexual partners.[9] As of 2022, The CDC reports that 48% of African American women and 46% of African American males in the United States are infected with the HSV-2 virus. [18][19]
Canada
According to a study in Ontario, of people between the ages of 15 and 16, 26.9% of men, 32% of non-pregnant women, and 55% of pregnant women tested positive for HSV-1 antibodies. Between the ages of 40 and 44, 54.7% of men, 88.7% of women, and 69.2% of pregnant women tested positive for HSV-1 antibodies. The overall age-gender standardized seroprevelance for HSV-1 antibodies was 51.1%.[20] Teenagers are less likely to be seropositive for HSV-2—antibodies against this virus are only found in 0–3.8% of 15- and 16-year-olds. However, 21% of individuals in their early forties have antibodies against HSV-2, reflecting the sexually transmitted nature of this virus. When standardising for age, HSV-2 seroprevalence in Ontario for individuals between the ages of 15 and 44 was 9.1%. Rates for Canadian people infected with HSV-2 is much lower than estimated levels of HSV-2 seroprevalence in people of a similar age range in the United States.[20]
HSV-2 seroprevalence in pregnant women between the ages of 15 and 44 in British Columbia is similar, with 57% having antibodies for HSV-1 and 13% having antibodies for HSV-2.[3] In British Columbia in 1999, the seroprevalence of HSV-2 antibody in leftover serum submitted for antenatal testing revealed a prevalence of 17.3%, ranging from 7.1% in women 15–19 years old to 28.2% in those 40–44 years.[21] • In attendees at an Alberta sexually transmitted infection (STI) clinic in 1994 and 1995, the seroprevalence of HSV-1 and -2 in leftover sera was 56% and 19%, respectively.[22] In Nova Scotia, 58.1% of 1,790 HSV isolates from genital lesion cultures in women were HSV-1; in men, 36.7% of 468 isolates were HSV-1[23]
Africa
Sub-Saharan Africa
HSV-2 is more common in Sub-Saharan Africa than in Europe or the North America. Up to 82% of women and 53% of men in Sub-Saharan Africa are seropositive for HSV-2. These are the highest levels of HSV-2 infection in the world, although exact levels vary from country to country in this continent.[24]
In most African countries, HSV-2 prevalence increases with age. However, age-associated decreases in HSV-2 seroprevalence has been observed for women in Uganda and Zambia, and in men in Ethiopia, Benin, and Uganda.[3]
Northern Africa
Genital herpes appears less common in Northern Africa compared to Sub-Saharan Africa. For example, only 26% of middle-aged women have antibodies for HSV-2 in Morocco.[5] Women are more likely to be infected with HSV-2 once they are over the age of 40.[5]
Children in Egypt with acute lymphoblastic leukemia are often infected with HSV from a young age—HSV-1 or HSV-2 antibodies are present in an estimated 54% of children under the age of 5, and 77% in children over 10 years of age.[25] Algerian children are also likely to acquire HSV-1 infection at a young age (under 6) and 81.25% of the population has antibodies to HSV-1 by the age of 15.[26]
Central and South America
Relative to rates in Europe and North America, HSV-2 seroprevalency is high in Central and South America. Infection levels are estimated at 20% to 60%.[3][24] During the mid-1980s, HSV-2 prevalence was 33% in 25- to 29-year-old women and 45% in those aged 40 and over in Costa Rica. In the early 1990s HSV-2 prevalence was approximately 45% among women over 60 in Mexico.[3]
The highest HSV-2 prevalence in Central or South America—60%—has been found in Colombian middle-aged women, although similar HSV-2 prevalence has been observed in younger women in Haiti (54%).[3] HSV-2 infects about 30% of women over 30 years old in Colombia, Costa Rica, Mexico, and Panama. HSV-2 antibodies were found in more than 41% of women of childbearing age in Brazil.[3]
However, no increase in seroprevalence was associated with age in women over 40 years old in Brazil—HSV-2 prevalence was estimated at 50% among women aged 40–49, 33% among women 50–59, and 42% among women over 60. Women in Brazil are more likely to acquire an HSV-2 infection if their male partners had history of anal sex and had many sexual partners in his lifetime.[5] In Peru, HSV-2 prevalence is also high among women in their 30s but is lower in men.[3]
Asia
Eastern and South East Asia
HSV-1 seroprevalence in some Asian countries is low, relative to other countries worldwide, with only 51% women in
In South Korea, incidence of HSV-2 infection in those under the age of 20 is low, only 2.7% in men and 3.0% in women.[6] Seroprevalence levels increase in older South Koreans however, such that the population over 20 that has antibodies against HSV-2 is 21.7% of men and 28% of women.[6]
Southern Asia
In India 63% of individuals were seropositive in 2005, within this figure, 33.3% were positive for HSV-1 and 16.6% are seropositive for HSV-2. Those with both HSV-1 and HSV-2 antibodies are estimated at 13.3% of the population. Indian men are more likely to be infected with HSV-2 than women, and increasing seroprevalence of this virus is associated with an increasing age.[28]
West Asia
Turkey— High levels of HSV-1 (97%) and HSV-2 (42%) were found amongst pregnant women in the city of
Jordan— The prevalence of HSV-2 in Jordan is 52.8% for men and 41.5% for women.[30]
Israel— HSV-1 seroprevalence is 59.8% in the population of Israel and increases with age in both genders but the adolescent seroprevalence has been declining as in most industrialized nations.[31] An estimated 9.2% of Israeli adults are infected with HSV-2. Infection of either HSV-1 or HSV-2 is higher in females; HSV-2 seroprevalence reaches 20.5% in females in their 40s. These values are similar to levels in HSV infection in Europe.[32]
Antibodies for HSV-1 or HSV-2 are also more likely to be found individuals born outside of Israel, and individuals residing in
Syria— Genital herpes infection from HSV-2 is predicted to be low in Syria although HSV-1 levels are high. HSV-1 infections is common (95%) among healthy Syrians over the age of 30, while HSV-2 prevalence is low in healthy individuals (0.15%), and persons infected with other sexually transmitted diseases (9.5%). High risk groups for acquiring HSV-2 in Syria, include prostitutes and bar girls; they have 34% and 20% seroprevalence respectively.[36]
Oceania
In Australia, a study using data from 1999 revealed the seroprevalence of HSV-1 was at 76.5%, with significant differences associated with age, gender and Indigenous status, which were not specified.[37] An estimated 12% of Australian adults were seropositive for HSV-2, with higher prevalence in women (16%) than in men (8%).[37] Larger cities had higher HSV-2 seroprevalence (13%) than rural populations (9%). Higher prevalence was found in Indigenous Australians (18%) than non-Indigenous Australians (12%).[37]
As in the U.S., HSV-1 is increasingly identified as the cause of genital herpes in Australians; HSV-1 was identified in the anogenital area of only 3% of the population in 1980, but had risen to 41% in 2001.[38] This was most common in females and persons under 25.[38] The number of genital herpes infections appears to be rising in New Zealand with three times more cases in 1993 compared to 1977.[39] In this country, HSV-2 affects 60% more women than men of similar age.[3]
References
- ISBN 978-0-521-82714-0.
- S2CID 41426466.
- ^ PMID 12353183.
- S2CID 2969472.
- ^ S2CID 16278674.
- ^ PMID 18162706.
- ^ PMID 15170000.
- ^ PMID 20414188. Retrieved 12 April 2011.
- ^ PMID 17939933.
- S2CID 36482043.
- S2CID 9464462.[permanent dead link]
- PMID 15115626.
- PMID 16926356.
- ^ "Herpes simplex". University of Maryland Medical Center. Retrieved 2007-09-03.
- ASHA Herpes Resource Center. Archived from the originalon 2007-09-14. Retrieved 2007-09-03.
- ^ "STD Facts – Genital Herpes". Centers for Disease Control and Prevention. Retrieved 2007-09-03.
- ^ "Herpes". Stanford University Sexual Health Peer Resource Center. Archived from the original on 2007-10-11. Retrieved 2007-09-03.
- ^ "CDC: Genital Herpes Rates Still High". Centers for Disease Control and Prevention. Retrieved 2011-02-03.
- ^ "UPDATE: CDC Stands Behind Report That Half of BLack Women Have Herpes". NewsOne. 2010-04-22. Retrieved 2011-02-03.
- ^ PMID 12517830.
- S2CID 6398806.
- S2CID 760586.
- PMID 18159431.
- ^ PMID 15115627.
- PMID 16883441.
- PMID 2562258.
- S2CID 24345509.
- PMID 17278662.
- ^ S2CID 31433518.
- PMID 10939038.
- S2CID 25659811.[permanent dead link]
- ^ PMID 16213591.
- S2CID 13077865.[permanent dead link]
- PMID 14509150.
- S2CID 25419267.
- PMID 11533818.
- ^ PMID 16581748.
- ^ PMID 16731681.
- PMID 8001945.